FILTER
FILTERED INTERVIEW RESULTS
Ricardo Diogo
DIRECTOR BUSINESS DEVELOPMENT, OILTANKING
A look at the liquids storage market in Latin America and its potential consolidation.
Matthias Vorbeck & Alejandro Gabrielli
GENERAL MANAGER & REGIONAL MANAGER, ANASTACIO OVERSEAS
The company continues expanding in Latin America capitalizing the synergies with the distribution business of Química Anastacio.
Alexandra Almenara
GENERAL MANAGER, SNC-LAVALIN PERU
SNC-Lavalin is enjoying a swift recovery in Peru and elsewhere and is further developing its offering.
Juan Luis Kruger
CEO, MINSUR
GBR speaks to Minsur, a Peruvian mining company in the process of developing its Mina Justa copper asset.
James Bannantine
CEO, GREAT PANTHER SILVER
“Coricancha will provide a 75% increase in the production level for Great Panther Silver”
Overview 13th International Gold and Silver Symposium - Lima, 2018
Watch the video to hear their insights on the precious metals market fundamentals, the role of technology, and the challenges that Peru needs to tackle to boost its mining industry.
Australia Peru Chamber of Commerce - May 2018
Global Business Reports meets the Australia Peru Chamber of Commerce (APCCI) in Lima during their 3rd Casual Event in May 2018.
Suresh Vadnagra
EXECUTIVE GENERAL MANAGER OPERATIONS AMERICAS, MMG & PRESIDENT, MINERA LAS BAMBAS
MMG speaks to GBR about the first year of production at the vast Las Bambas copper mine.
Manuel Fumagalli
PRESIDENT, ORGANIZING COMMITTEE, 13TH INT. GOLD AND SILVER SYMPOSIUM
This year’s International Gold and Silver Symposium, taking place on 29th of May in Peru, will focus on technology and innovation.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
